CURRENT
ISSUE
1565
February 11, 2019
Cholesterol management guidelines from the American College of Cardiology/American Heart Association Task Force have recently been published. See Table 1 for a brief summary of their recommendations....  Continue reading
More from Issue 1565
Previous Issue: 1564      January 28, 2019
Coming Soon
Cardiovascular Benefits of SGLT2 Inhibitors and GLP-1 Receptor Agonists in Type 2 Diabetes
Drug Interaction: Opioids and Oral P2Y12 Platelet Inhibitors
Elderberry for Influenza
Oxybutynin for Hot Flashes in Women with Breast Cancer
Drugs for Gout
Search
Subscribe
Conversation
Follow us  facebook        Email Alerts
 Tweets
Advance Release
ADVANCE
RELEASE

The FDA has approved a manually injected, single-dose, prefilled epinephrine syringe (Symjepi – Adamis/Sandoz) for emergency treatment of anaphylaxis. The new device is approved in 0.3- and 0.15-mg strengths for treatment of patients weighing ≥30 kg and 15 to 30 kg, respectively; only the 0.3-mg strength is currently available. According to Sandoz, Symjepi will be made available first to institutions and later to the retail market.

EPINEPHRINE ... Continue reading